These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 19360860)
1. Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention. Lemesle G; De Labriolle A; Bonello L; Syed A; Collins S; Maluenda G; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R Catheter Cardiovasc Interv; 2009 Sep; 74(3):428-35. PubMed ID: 19360860 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes. Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice. Kim LK; Wong SC; Minutello RM; Bergman G; Feldman DN J Invasive Cardiol; 2010 Mar; 22(3):94-100. PubMed ID: 20197573 [TBL] [Abstract][Full Text] [Related]
4. Oldies but goodies. Butman SM Catheter Cardiovasc Interv; 2009 Sep; 74(3):436-7. PubMed ID: 19681122 [No Abstract] [Full Text] [Related]
5. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Steinberg DH; Shah P; Kinnaird T; Pinto Slottow TL; Roy PK; Okabe T; Bonello L; de Labriolle A; Smith KA; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2008 Jul; 102(2):160-4. PubMed ID: 18602514 [TBL] [Abstract][Full Text] [Related]
6. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW; JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378 [TBL] [Abstract][Full Text] [Related]
7. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. Mehran R; Pocock S; Nikolsky E; Dangas GD; Clayton T; Claessen BE; Caixeta A; Feit F; Manoukian SV; White H; Bertrand M; Ohman EM; Parise H; Lansky AJ; Lincoff AM; Stone GW JACC Cardiovasc Interv; 2011 Jun; 4(6):654-64. PubMed ID: 21700252 [TBL] [Abstract][Full Text] [Related]
9. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use. Kini AS; Rafael OC; Sarkar K; Rajdev S; Jakkula M; Mares AM; Kaplish D; Krishnan P; Kim MC; Sharma SK Catheter Cardiovasc Interv; 2009 Nov; 74(5):700-7. PubMed ID: 19496119 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study. Cortese B; Micheli A; Picchi A; Bandinelli L; Brizi MG; Severi S; Limbruno U Coron Artery Dis; 2009 Aug; 20(5):348-53. PubMed ID: 19543084 [TBL] [Abstract][Full Text] [Related]
11. Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial. Sanborn TA; Tomey MI; Mehran R; Généreux P; Witzenbichler B; Brener SJ; Kirtane AJ; McAndrew TC; Kornowski R; Dudek D; Nikolsky E; Stone GW Catheter Cardiovasc Interv; 2015 Feb; 85(3):371-9. PubMed ID: 25179260 [TBL] [Abstract][Full Text] [Related]
12. Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents. Feldman DN; Wong SC; Gade CL; Gidseg DS; Bergman G; Minutello RM Am Heart J; 2007 Oct; 154(4):695-701. PubMed ID: 17892994 [TBL] [Abstract][Full Text] [Related]
13. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. Verheugt FW; Steinhubl SR; Hamon M; Darius H; Steg PG; Valgimigli M; Marso SP; Rao SV; Gershlick AH; Lincoff AM; Mehran R; Stone GW JACC Cardiovasc Interv; 2011 Feb; 4(2):191-7. PubMed ID: 21349458 [TBL] [Abstract][Full Text] [Related]
14. Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention. Iijima R; Ndrepepa G; Mehilli J; Byrne RA; Schulz S; Neumann FJ; Richardt G; Berger PB; Schömig A; Kastrati A Eur Heart J; 2009 Feb; 30(3):290-6. PubMed ID: 19147609 [TBL] [Abstract][Full Text] [Related]
15. The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium. Sukul D; Seth M; Schreiber T; Khandelwal A; Cannon LA; LaLonde TA; Gurm HS Catheter Cardiovasc Interv; 2017 Nov; 90(5):724-732. PubMed ID: 28303632 [TBL] [Abstract][Full Text] [Related]
16. Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials. Yu J; Mehran R; Clayton T; Gibson CM; Brodie BR; Witzenbichler B; Lincoff AM; Deliargyris EN; Gersh BJ; Pocock SJ; Stone GW; Dangas GD Catheter Cardiovasc Interv; 2016 Feb; 87(3):391-400. PubMed ID: 26624854 [TBL] [Abstract][Full Text] [Related]
17. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry. Jovin IS; Shah RM; Patel DB; Rao SV; Baklanov DV; Moussa I; Kennedy KF; Secemsky EA; Yeh RW; Kontos MC; Vetrovec GW JACC Cardiovasc Interv; 2017 Jun; 10(11):1102-1111. PubMed ID: 28527778 [TBL] [Abstract][Full Text] [Related]
18. Association between arterial access site and anticoagulation strategy on major bleeding and mortality: A historical cohort analysis in the Veteran population. Bagai J; Little B; Banerjee S Cardiovasc Revasc Med; 2018; 19(1 Pt B):95-101. PubMed ID: 28624360 [TBL] [Abstract][Full Text] [Related]
19. Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty. Kini A; Yu J; Cohen MG; Mehran R; Baber U; Sartori S; Vlachojannis GJ; Kovacic JC; Pyo R; O'Neill B; Singh V; Jacobs E; Poludasu S; Moreno P; Kim MC; Krishnan P; Sharma SK; Dangas GD EuroIntervention; 2014 Jul; 10(3):312-9. PubMed ID: 24273237 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ; JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]